Federal Register/Vol. 76, No. 228/Monday, November

Federal Register/Vol. 76, No. 228/Monday, November

Federal Register / Vol. 76, No. 228 / Monday, November 28, 2011 / Notices 72975 Dated: November 18, 2011. Drug Schedule (ODL), 8701 Morrissette Drive, Joseph T. Rannazzisi, Springfield, Virginia 22152; and must be Deputy Assistant Administrator, Office of 4-Anilino-N-phenethyl-4-piperidine II filed no later than January 27, 2012. (8333). Diversion Control, Drug Enforcement Dated: November 18, 2011. Administration. Codeine (9050) ............................. II Oxycodone (9143) ........................ II Joseph T. Rannazzisi, [FR Doc. 2011–30547 Filed 11–25–11; 8:45 am] Hydromorphone (9150) ................ II Deputy Assistant Administrator, Office of BILLING CODE 4410–09–P Hydrocodone (9193) ..................... II Diversion Control, Drug Enforcement Levorphanol (9220) ...................... II Administration. Methadone (9250) ........................ II [FR Doc. 2011–30544 Filed 11–25–11; 8:45 am] DEPARTMENT OF JUSTICE Methadone intermediate (9254) ... II BILLING CODE 4410–09–P Morphine (9300) ........................... II Drug Enforcement Administration Thebaine (9333) ........................... II Oxymorphone (9652) ................... II Manufacturer of Controlled DEPARTMENT OF JUSTICE Substances Notice of Application The company plans to manufacture Drug Enforcement Administration Pursuant to § 1301.33(a), Title 21 of the listed controlled substances as bulk the Code of Federal Regulations (CFR), controlled substances intermediates for Manufacturer of Controlled this is notice that on March 30, 2010, distribution to its customers. Substances Notice of Registration Mallinckrodt Inc., 675 McDonnell Blvd., Any other such applicant, and any Hazelwood, Missouri 63042, made person who is presently registered with By Notice dated June 1, 2011 and application to the Drug Enforcement DEA to manufacture such substances, published in the Federal Register on Administration (DEA) to be registered as may file comments or objections to the June 9, 2011, 76 FR 33785, Alltech a bulk manufacturer of the following issuance of the proposed registration Associates Inc., 2051 Waukegan Road, basic classes of controlled substances: pursuant to 21 CFR 1301.33(a). Deerfield, Illinois 60015, made Any such written comments or application by renewal to the Drug Drug Schedule objections should be addressed, in Enforcement Administration (DEA) to quintuplicate, to the Drug Enforcement be registered as a bulk manufacturer of Amphetamine (1100) .................... II Administration, Office of Diversion the following basic classes of controlled Methylphenidate (1724) ................ II Control, Federal Register Representative substances: Drug Schedule Methcathinone (1237) .................................................................................................................................................................................. I N-Ethylamphetamine (1475) ........................................................................................................................................................................ I N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. I 4-Methylaminorex (cis isomer) (1590) ......................................................................................................................................................... I Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... I Lysergic acid diethylamide (7315) ............................................................................................................................................................... I 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ............................................................................................................................... I Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I Mescaline (7381) ......................................................................................................................................................................................... I 4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I 4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I 4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I 2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I 2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................ I 3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I N-Hydroxy-3,4-methylenedioxyamphetamine (7402) .................................................................................................................................. I 3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I 3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I 4-Methoxyamphetamine (7411) ................................................................................................................................................................... I Alpha-methyltryptamine (7432) ................................................................................................................................................................... I Bufotenine (7433) ........................................................................................................................................................................................ I Diethyltryptamine (7434) ............................................................................................................................................................................. I Dimethyltryptamine (7435) .......................................................................................................................................................................... I Psilocybin (7437) ......................................................................................................................................................................................... I Psilocyn (7438) ............................................................................................................................................................................................ I 5-Methoxy-N,N-diisopropyltryptamine (7439) .............................................................................................................................................. I N-Ethyl-1-phenylcyclohexylamine (7455) .................................................................................................................................................... I 1-(1-Phenylcyclohexyl)pyrrolidine (7458) .................................................................................................................................................... I 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ............................................................................................................................................... I Dihydromorphine (9145) .............................................................................................................................................................................. I Normorphine (9313) .................................................................................................................................................................................... I Methamphetamine (1105) ........................................................................................................................................................................... II 1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. II Phencyclidine (7471) ................................................................................................................................................................................... II Phenylacetone (8501) ................................................................................................................................................................................. II 1-Piperidinocyclohexanecarbonitrile (8603) ...............................................................................................................................................

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    1 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us